SPY303.53+4.45 1.49%
DIA255.77+5.52 2.21%
IXIC9,412.36+72.14 0.77%

Credit Suisse Maintains Outperform on Acceleron Pharma, Raises Price Target to $123

Credit Suisse maintains Acceleron Pharma (NASDAQ:XLRN) with a Outperform and raises the price target from $99 to $123.

Benzinga · 05/08/2020 14:34

Credit Suisse maintains Acceleron Pharma (NASDAQ:XLRN) with a Outperform and raises the price target from $99 to $123.